Summary:

- The article discusses the development of a novel anti-tau therapy, which aims to target the tau protein that is implicated in the progression of Alzheimer's disease and other neurodegenerative disorders.
- Researchers have identified a small molecule inhibitor that can disrupt the aggregation of tau proteins, preventing them from forming the neurofibrillary tangles that are characteristic of Alzheimer's disease.
- The article highlights the potential of this novel therapy to provide a new approach to treating Alzheimer's and other tau-related neurodegenerative diseases, which currently have limited treatment options.